Read + Share
Amedeo Smart
Independent Medical Education
Kahlert CR, Cipriani M, Vernazza P. Novel dual HIV maintenance therapy with nevirapine plus lamivudine retain viral suppression through 144 weeks-A proof-of-concept study. PLoS One 2020;15:e0237770.PMID: 32966293
Email
LinkedIn
Facebook
Twitter
Privacy Policy